News
APNewsBreak: SC man sues eye centers after Lasik
6 hours ago
A federal lawsuit filed Wednesday in South Carolina accuses eye clinics across the country of performing surgeries on patients with pre-existing conditions that should have excluded them as candidates, causing those patients to suffer post-operative problems.Practitioners in 30 TLC LASIK...
Synergetics 2Q profit doubles on cost cutting
6 hours ago
Surgical equipment maker Synergetics USA Inc. said Wednesday that its profit more than doubled in its fiscal second quarter as it cut back on sales and marketing spending.In the quarter ended Jan. 31, the company's profit rose to $877,000, or 4 cents per share, from $389,000, or 2 cents per...
Report questions excluding gays from some studies
7 hours ago
A small but significant portion of medical studies exclude gays from participating, sometimes without an apparent scientific reason, several cancer researchers say.In a letter in Thursday's New England Journal of Medicine, three scientists from the Fox Chase Cancer Center in Philadelphia cite...
SurModics licenses technology from ForSight Labs
7 hours ago
SurModics Inc. said Wednesday that it licensed ophthalmology technology from ForSight Labs LLC for an undisclosed sum.The medical technology company said the deal includes an upfront license payment, milestone payments, and royalties. SurModics said the deal does not include ForSight's I-vation...
Research monkey deaths prompt calls for crackdown
8 hours ago
Workers at a Nevada research lab were checking on a primate room when they came across a ghastly sight: Thirty dead monkeys were essentially cooked alive after someone left the heater on. Two others were near death and had to be euthanized.At a lab run by the same company, a monkey died last...
Disabling Skp2 gene helps shut down cancer growth
9 hours ago
(University of Texas M. D. Anderson Cancer Center) Increased understanding of the Skp2 gene and its relation to cellular senescence may lead to the development of novel agents that can suppress tumor development in common types of cancer, researchers from the University of Texas M....
DiagnoCure reports deeper $3.8-million loss in Q1; CFO to leave his role
9 hours ago
DiagnoCure Inc. (TSX:CUR) says its losses deepened to $3.8 million in its first quarter as the life-sciences firm reworked the structure of the company and announced the exit of its chief financial officer.The Quebec-based company reported a loss of nine cents per share for the period ended...
J&J CEO Weldon gets 11 pct 2009 raise, to $25.6M
10 hours ago
The Associated Press finds Johnson & Johnson's chief executive got an 11 percent raise in 2009, even though the health giant saw revenue fall for the first time since the Depression.Bill Weldon received 2009 compensation valued at $25.6 million, based on figures in a regulatory filing.The New...
Teva and Merck agree on generic Temodar launch
11 hours ago
Teva Pharmaceutical Industries Ltd. said Wednesday it agreed to hold off on launching a generic version of Merck & Co.'s cancer drug Temodar until a federal appeals court weighs in on the drug's patent.Instead of launching its generic version of Temodar now, Teva said it will begin selling its...